Mursla Bio
$2.2M
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
Mursla Bio is currently valued at $53.2M as of April 18, 2025. The company has raised a total of $10.2M in funding.
Capital Efficiency
With a capital efficiency ratio of 5.21x, Mursla Bio has achieved a valuation that is 5.21 times the total capital raised. This metric indicates strong capital efficiency and effective deployment of investor funds.
Investment Perspective
Mursla Bio's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is Mursla Bio Worth in 2025?
As of 2025, Mursla Bio is valued at $53.2M, based on the company's Later Stage VC funding round in April 18, 2025. This valuation positions Mursla Bio as one of the leading private companies in the sector.
Mursla Bio Valuation History
Mursla Bio's funding history demonstrates steady growth and investor confidence.
How Mursla Bio Valuation is Determined
Private company valuations like Mursla Bio's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
Mursla Bio Valuation FAQs
Is Mursla Bio profitable?
Mursla Bio has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does Mursla Bio's valuation compare to competitors?
Mursla Bio is valued at $53.2M, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will Mursla Bio IPO?
Mursla Bio has not announced plans for an initial public offering. Until an IPO, investors can access Mursla Bio shares through secondary market platforms.